Published in Sci Rep on August 01, 2017
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Hallmarks of cancer: the next generation. Cell (2011) 140.01
The sequence of the human genome. Science (2001) 101.55
Integrated genomic analyses of ovarian carcinoma. Nature (2011) 47.72
Comprehensive molecular portraits of human breast tumours. Nature (2012) 47.39
Regulation of cancer cell metabolism. Nat Rev Cancer (2011) 15.44
The landscape of cancer genes and mutational processes in breast cancer. Nature (2012) 11.24
Clonal evolution in cancer. Nature (2012) 11.07
Deep learning. Nature (2015) 10.01
Exploring the genomes of cancer cells: progress and promise. Science (2011) 6.16
What is a support vector machine? Nat Biotechnol (2006) 5.10
Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer (2008) 4.25
CellNet: network biology applied to stem cell engineering. Cell (2014) 4.10
A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes. Proc Natl Acad Sci U S A (2008) 3.57
RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease. Science (2014) 3.48
From 'differential expression' to 'differential networking' - identification of dysfunctional regulatory networks in diseases. Trends Genet (2010) 2.97
Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes. Nat Genet (2014) 2.91
Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat Rev Cancer (2006) 2.90
Nuclear transport and cancer: from mechanism to intervention. Nat Rev Cancer (2004) 2.85
Genomic analyses identify molecular subtypes of pancreatic cancer. Nature (2016) 2.70
Sumoylation: a regulatory protein modification in health and disease. Annu Rev Biochem (2013) 2.66
Machine learning and its applications to biology. PLoS Comput Biol (2007) 2.57
Cancer: a Systems Biology disease. Biosystems (2006) 2.29
Tracing the cellular origin of cancer. Nat Cell Biol (2013) 1.75
KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia. Br J Haematol (2013) 1.68
Expanding the computational toolbox for mining cancer genomes. Nat Rev Genet (2014) 1.60
The ubiquitin-proteasome pathway in cancer. Br J Cancer (1998) 1.56
Computational methods for discovering gene networks from expression data. Brief Bioinform (2009) 1.52
Of cancer and cave fish. Nat Rev Cancer (2011) 1.50
Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosis. Cancer Res (2006) 1.41
Machine learning applications in genetics and genomics. Nat Rev Genet (2015) 1.32
Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth. Cancer Res (2009) 1.20
Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein. J Biol Chem (2010) 1.14
Effect of selection of molecular descriptors on the prediction of blood-brain barrier penetrating and nonpenetrating agents by statistical learning methods. J Chem Inf Model (2005) 1.05
Efficient key pathway mining: combining networks and OMICS data. Integr Biol (Camb) (2012) 1.05
Silencing HoxA1 by intraductal injection of siRNA lipidoid nanoparticles prevents mammary tumor progression in mice. Sci Transl Med (2014) 1.03
Exploiting protein-protein interaction networks for genome-wide disease-gene prioritization. PLoS One (2012) 0.98
In silico prediction of pregnane X receptor activators by machine learning approaches. Mol Pharmacol (2006) 0.98
Evolutionary triage governs fitness in driver and passenger mutations and suggests targeting never mutations. Nat Commun (2014) 0.97
A single source k-shortest paths algorithm to infer regulatory pathways in a gene network. Bioinformatics (2012) 0.96
KeyPathwayMiner 4.0: condition-specific pathway analysis by combining multiple omics studies and networks with Cytoscape. BMC Syst Biol (2014) 0.95
RNA splicing factors as oncoproteins and tumour suppressors. Nat Rev Cancer (2016) 0.92
Perspective: Finding cancer's first principles. Nature (2012) 0.88
Connecting the dots: applications of network medicine in pharmacology and disease. Clin Pharmacol Ther (2013) 0.88
Deep learning for computational biology. Mol Syst Biol (2016) 0.88
Polymorphisms in thymidylate synthase and reduced folate carrier (SLC19A1) genes predict survival outcome in advanced non-small cell lung cancer patients treated with pemetrexed-based chemotherapy. Oncol Lett (2013) 0.86
Tissue-specific regulatory circuits reveal variable modular perturbations across complex diseases. Nat Methods (2016) 0.84
The Essential Role of H19 Contributing to Cisplatin Resistance by Regulating Glutathione Metabolism in High-Grade Serous Ovarian Cancer. Sci Rep (2016) 0.83
Changes in nuclear RNA transport incident to carcinogenesis. Eur J Cancer (1977) 0.79
Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer. Cancer Res (2016) 0.78
Cell type-specific properties and environment shape tissue specificity of cancer genes. Sci Rep (2016) 0.78
Tissue-specific tumorigenesis: context matters. Nat Rev Cancer (2017) 0.77
Integrative analysis of deep sequencing data identifies estrogen receptor early response genes and links ATAD3B to poor survival in breast cancer. PLoS Comput Biol (2013) 0.77
A Robust and Efficient Feature Selection Algorithm for Microarray Data. Mol Inform (2016) 0.77
On the performance of de novo pathway enrichment. NPJ Syst Biol Appl (2017) 0.76
Compensation of feature selection biases accompanied with improved predictive performance for binary classification by using a novel ensemble feature selection approach. BioData Min (2016) 0.75
NetDecoder: a network biology platform that decodes context-specific biological networks and gene activities. Nucleic Acids Res (2016) 0.75
Placenta-Enriched LincRNAs MIR503HG and LINC00629 Decrease Migration and Invasion Potential of JEG-3 Cell Line. PLoS One (2016) 0.75
ZSCAN10 expression corrects the genomic instability of iPSCs from aged donors. Nat Cell Biol (2017) 0.75